What is Bumrungrad Hospital Public Company Limited (BUGDF)?

Bumrungrad Hospital Public Company Limited (BUGDF) is a stock in the Healthcare sector, Medical - Care Facilities industry. View full analysis on Stocks360.

What is the current price of BUGDF?

The current price of BUGDF is $4.75. Prices are updated in real time on Stocks360.

What is BUGDF's price-to-earnings (PE) ratio?

BUGDF's trailing twelve-month PE ratio is 21.03, based on current price and earnings per share data available on Stocks360.

What is BUGDF's market capitalization?

BUGDF's market capitalization is $3,776,091,312.00, placing it in the mid-cap tier.

Does BUGDF pay a dividend?

Yes. BUGDF has a trailing twelve-month dividend yield of 0.06%. Dividend data is sourced from financial market providers and displayed on Stocks360.

Bumrungrad Hospital Public Company Limited (BUGDF)

Stock analysis · OTC · Healthcare · Medical - Care Facilities

$4.75

Market Cap

$3.78B

PE (TTM)

21.03

EPS (TTM)

N/A

Dividend Yield

6.47%

Beta

0.18

Day Range

$4.75 – $4.75

52-wk Range

$3.95 – $6.31

Avg Volume

N/A

Volume

0.00

Bumrungrad Hospital Public Company Limited (BUGDF) is a publicly traded company in the Healthcare sector. Latest price: $4.75. Market cap $3.78B. Trailing PE 21.03. Dividend yield 6.47%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 6 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-30 · $4.23 2026-10-26 · $4.75 (+12.29%)

Earnings

Most Recent

Aug 14, 2026

EPS $0.07 vs est. $0.07

Missed by $0.00

Next Earnings

Nov 5, 2026

EPS estimate $0.08

Proprietary Signals

Signal snapshot temporarily unavailable.

About Bumrungrad Hospital Public Company Limited

Bumrungrad Hospital Public Company Limited (BUGDF) is a leading healthcare provider that operates a network of medical facilities in Thailand and globally. Its core offering is a comprehensive medical center equipped with advanced diagnostic, therapeutic, and intensive care capabilities. The company also boasts an extensive array of approximately 56 specialized outpatient clinics and centers, covering a broad spectrum of medical disciplines. These include, but are not limited to, allergy, cardiology, behavioral health, oncology, dental, diabetes, emergency services, eye care, fertility, digestive disease, women's health, men's health, orthopedics, physical therapy, plastic surgery, and sleep medicine. Beyond direct patient care, Bumrungrad engages in various related activities. These encompass managing real estate holdings, conducting clinical research, distributing pharmaceutical and medical goods through dedicated stores, operating a training and development center for healthcare professionals, and providing patient referral services. With its substantial infrastructure, the company maintains 580 hospital beds across its facilities. Founded in 1980, Bumrungrad Hospital Public Co…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	21.03×
P/S (TTM)	6.27×
P/B	5.91×
PEG	10.37×
P/FCF (TTM)	34.09×
EV / EBITDA	15.25×
EV / Sales	6.14×
Earnings Yield	4.76%
Free Cash Flow Yield	2.93%
Dividend Yield	6.47%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$156.30B
Revenue (TTM)	$25.47B
Net Income (TTM)	$7.60B
Free Cash Flow (TTM)	$4.49B
Net Debt	-$3.49B
Working Capital	$10.04B
Gross Margin	51.87%
Operating Margin	34.57%
Net Margin	29.84%
Return on Equity	25.54%
Return on Invested Capital	24.73%